Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 12/20 | 0.65 |
| ▸ | ESR1 | P03372 | 6/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL220950 | 1.00 | ESR2 (0.65) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL17866683 | 0.98 | ESR2 (0.63) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL9379991 | 0.98 | ESR2 (0.63) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL27650866 | 0.98 | ESR2 (0.63) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL9815696 | 0.98 | ESR2 (0.63) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL9379988 | 0.98 | ESR2 (0.63) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL19722185 | 0.98 | ESR2 (0.63) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL17866684 | 0.98 | ESR2 (0.63) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL4337530 | 0.98 | ESR2 (0.63) | ESR2ESR1CYP2C9CYP3A4CYP2D6 | |
| SCHEMBL21321769 | 0.95 | ESR2 (0.59) | ESR2ESR1CYP2C9CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114656334-B | Phenolic oligomer, preparation method thereof and asphaltene deposition inhibitor composition | 中国石油化工股份有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-114763469-B | Oil-soluble paraffin removal and prevention agent and preparation method thereof | 中国石油化工股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-114763469-A | Oil-soluble paraffin removal and prevention agent and preparation method thereof | 中国石油化工股份有限公司 | 2022-07-19 | — | — | CN | disclosed |
| CN-114656334-A | Phenolic aldehyde oligomer, preparation method thereof and asphaltene deposition inhibitor composition | 中国石油化工股份有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-106701106-B | Alignment mechanism for optical dyes | 光学转变公司 | 2022-03-29 | — | — | CN | disclosed |
| EP-3202798-B1 | BLOCK COPOLYMER | LG CHEMICAL LTD (KR) | 2022-01-12 | — | — | EP | disclosed |
| CN-107033076-B | Polymerizable liquid crystal compound, composition, liquid crystal polymer films thereof, method for producing same, and use thereof | 捷恩智株式会社 | 2021-11-02 | — | — | CN | disclosed |
| US-10975307-B2 | Liquid crystalline epoxy compound with terminal mesogen connected by flexible linkage and method for preparing the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2021-04-13 | — | — | US | disclosed |
| US-10655066-B2 | Optical isomer | DIC CORPORATION (JP) | 2020-05-19 | — | — | US | disclosed |
| US-10581022-B2 | Polymerizable liquid crystal compound, composition, liquid crystal polymerization film-kind thereof and use thereof | JNC CORPORATION (JP) | 2020-03-03 | — | — | US | disclosed |
| EP-0388141-A1 | Ferroelectric liquid crystal device | SHARP KABUSHIKI KAISHA (JP) | 1990-09-19 | — | — | EP | disclosed |
| US-4909957-A | Containing lactone ring structure | DAISO CO., LTD. (JP) | 1990-03-20 | — | — | US | disclosed |
| EP-0357739-A1 | CHIRAL DERIVATIVES OF 1,2-DIFLUOROBENZENE | MERCK PATENT GmbH (DE) | 1990-03-14 | — | — | EP | disclosed |
| WO-1989008639-A1 | CHIRAL DERIVATIVES OF 1,2-DIFLUOROBENZENE | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1989-09-21 | — | — | WO | disclosed |
| EP-0332025-A1 | Chiral derivatives of 1,2-difluorobenzenes | MERCK PATENT GmbH (DE) | 1989-09-13 | — | — | EP | disclosed |
| EP-0306919-A2 | Liquid crystalline compounds and process for production thereof | DAISO CO., LTD. (JP) | 1989-03-15 | — | — | EP | disclosed |
| EP-0278665-A2 | 2-Substituted-alkyl ether and liquid crystal composition | Chisso Corporation (JP) | 1988-08-17 | — | — | EP | disclosed |
| EP-0168683-A2 | Liquid crystals with alkenyl or alkenyloxy groups | F. HOFFMANN-LA ROCHE AG (CH) | 1986-01-22 | — | — | EP | disclosed |
| US-4487954-A | LIQUID CRYSTALS | CHISSO CORPORATION (JP) | 1984-12-11 | — | — | US | disclosed |
| EP-0056113-A1 | Cyclohexylcarbonitrile derivatives, dielectrics and electro-optic display device containing them | MERCK PATENT GmbH (DE) | 1982-07-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10581022-B2 | Polymerizable liquid crystal compound, composition, liquid crystal polymerization film-kind thereof and use thereof | RCC1, CHRM1, PFN1 | ESR2 4809/4885ESR1 4691/4885CYP2C9 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.